Your browser doesn't support javascript.
loading
Tumor immunogenicity dictates reliance on TCF1 in CD8+ T cells for response to immunotherapy.
Escobar, Giulia; Tooley, Katherine; Oliveras, Joan Pagès; Huang, Linglin; Cheng, Hanning; Bookstaver, Michelle L; Edwards, Camilla; Froimchuk, Eugene; Xue, Chang; Mangani, Davide; Krishnan, Rajesh K; Hazel, Natanael; Rutigliani, Carola; Jewell, Christopher M; Biasco, Luca; Anderson, Ana C.
Afiliação
  • Escobar G; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Tooley K; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.
  • Oliveras JP; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Huang L; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Cheng H; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Bookstaver ML; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Edwards C; Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA.
  • Froimchuk E; Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA.
  • Xue C; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Mangani D; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Krishnan RK; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Hazel N; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Rutigliani C; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Jewell CM; Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA; US Department of Veterans Affairs, VA Maryland Health Care System, Baltimore, MD 21201, USA.
  • Biasco L; Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Anderson AC; Evergrande Center for Immunologic Diseases, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA. Electronic address: acanderson@bwh.harvard.edu.
Cancer Cell ; 41(9): 1662-1679.e7, 2023 09 11.
Article em En | MEDLINE | ID: mdl-37625402
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Fator 1 de Transcrição de Linfócitos T / Neoplasias Limite: Humans Idioma: En Revista: Cancer Cell Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Fator 1 de Transcrição de Linfócitos T / Neoplasias Limite: Humans Idioma: En Revista: Cancer Cell Ano de publicação: 2023 Tipo de documento: Article